|
|
Volumn 2, Issue 4, 2003, Pages 289-291
|
|
The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRCA1 PROTEIN;
BRD1 PROTEIN, HUMAN;
CISPLATIN;
FANCF PROTEIN, HUMAN;
FANCONI ANEMIA GROUP F PROTEIN;
NUCLEAR PROTEIN;
RNA BINDING PROTEIN;
CELL NUCLEUS;
CHROMOSOMAL INSTABILITY;
DNA METHYLATION;
DNA REPAIR;
DRUG EFFECT;
FANCONI ANEMIA;
FEMALE;
GENETICS;
HUMAN;
METABOLISM;
OVARY TUMOR;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
BRCA1 PROTEIN;
CELL NUCLEUS;
CHROMOSOMAL INSTABILITY;
CISPLATIN;
DNA METHYLATION;
DNA REPAIR;
FANCONI ANEMIA;
FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN;
FEMALE;
HUMANS;
NUCLEAR PROTEINS;
OVARIAN NEOPLASMS;
RNA-BINDING PROTEINS;
SIGNAL TRANSDUCTION;
MLCS;
MLOWN;
|
|
EID: 2342596529
PISSN: 15384101
EISSN: None
Source Type: Journal
DOI: 10.4161/cc.2.4.413 Document Type: Review |
|
Times cited : (60)
|
|
References (12)
|
